0001670747-20-000001.txt : 20200205
0001670747-20-000001.hdr.sgml : 20200205
20200205160110
ACCESSION NUMBER: 0001670747-20-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
EFFECTIVENESS DATE: 20200205
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BirchBioMed Inc.
CENTRAL INDEX KEY: 0001670747
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-260252
FILM NUMBER: 20578709
BUSINESS ADDRESS:
STREET 1: 130 KINGSCROSS DRIVE
CITY: KING CITY
STATE: A6
ZIP: L7B 1E6
BUSINESS PHONE: 866-350-1993
MAIL ADDRESS:
STREET 1: 130 KINGSCROSS DRIVE
CITY: KING CITY
STATE: A6
ZIP: L7B 1E6
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001670747
BirchBioMed Inc.
130 KINGSCROSS DRIVE
KING CITY
A6
ONTARIO, CANADA
L7B 1E6
866-350-1993
BRITISH COLUMBIA, CANADA
None
None
Corporation
true
2015
Mark
S.
Miller
130 Kingscross Drive
King City
A6
ONTARIO, CANADA
L7B 1E6
Executive Officer
Director
Promoter
Ryan
V.
Hartwell
130 Kingscross Drive
King City
A6
ONTARIO, CANADA
L7B 1E6
Executive Officer
Director
Promoter
Susan
M.
Elliott
130 Kingscross Drive
King City
A6
ONTARIO, CANADA
L7B 1E6
Executive Officer
Director
Promoter
Jon
Verbeck
130 Kingscross Drive
King City
A6
ONTARIO, CANADA
L7B 1E6
Executive Officer
Biotechnology
Decline to Disclose
- 06b
true
0001670747-19-000001
2016-05-20
false
true
false
100000
Maxim Group LLC
120708
None
None
405 Lexington Avenue
New York
NY
NEW YORK
10174
AZ
ARIZONA
CA
CALIFORNIA
FL
FLORIDA
IN
INDIANA
MN
MINNESOTA
NH
NEW HAMPSHIRE
NY
NEW YORK
OH
OHIO
PA
PENNSYLVANIA
TX
TEXAS
UT
UTAH
false
10000000
5302550
4697450
false
97
59200
true
0
true
Maxim Group received these fees from prior investments but has waived any commissions or finders fees for this offering going forward.
1719000
true
false
BirchBioMed Inc.
/s/ Mark S. Miller
Mark S. Miller
Chief Executive Officer
2020-02-03